Literature DB >> 7994801

DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy.

N Iwai1, N Ohmichi, Y Nakamura, M Kinoshita.   

Abstract

BACKGROUND: The cardiac renin-angiotensin system has been suggested to be involved in the development of left ventricular hypertrophy. In humans, a strong correlation has been found between plasma angiotensin I-converting enzyme (ACE) activity and the insertion/deletion (I/D) polymorphism of the ACE gene, which has been reported to be associated with myocardial infarction, ischemic and idiopathic dilated cardiomyopathy, sudden death in hypertrophic cardiomyopathy, and restenosis after percutaneous transluminal coronary angioplasty. In the present study, we examined the possibility that the genotype of the ACE gene might influence the development of left ventricular hypertrophy. METHODS AND
RESULTS: The study population consisted of 268 subjects randomly selected from our outpatient clinic. In 142 subjects, left ventricular mass (LVM) was determined by echocardiogram. The genotype of the ACE gene was determined by the polymerase chain reaction. ANCOVA revealed that the genotype of the ACE gene had no effect on blood pressure. The percentage of the explained variance of LVM with variables including diastolic blood pressure (DBP, P = .0001), body mass index (BMI, P = .0001), sex (P = .0009), and the genotype of the ACE gene (P = .0017) was 34.61%. Significant differences in the effects of the genotype of the ACE gene on LVM were observed between the II and DD (P = .0004) and between the ID and DD (P = .0077) genotypes. The percentage of the explained variance of the LVM/ht ratio with variables including sex (P = .134), age (P = .3655), the genotype of the ACE gene (P = .0014), BMI (P = .0001), and DBP (P = .0001) was 31.25%. Significant differences in the effects of the genotype of the ACE gene on LVM/ht were observed between the II and DD genotypes (P = .0003) and between the ID and DD genotypes (P = .0091).
CONCLUSIONS: In addition to BMI and DBP, the genotype of the ACE gene was a significant predictor of LVM and LVM/ht in our study population.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7994801     DOI: 10.1161/01.cir.90.6.2622

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  23 in total

Review 1.  Angiotensin I-converting enzyme: genotype and disease associations.

Authors:  D Crisan; J Carr
Journal:  J Mol Diagn       Date:  2000-08       Impact factor: 5.568

2.  Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries.

Authors:  M Hamon; C Amant; C Bauters; F Richard; N Helbecque; E McFadden; J M Lablanche; M Bertrand; P Amouyel
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

3.  Angiotensin-converting enzyme gene deletion allele increases the risk of left ventricular hypertrophy: evidence from a meta-analysis.

Authors:  Xiaobo Li; Yuqiong Li; Nan Jia; Shujie Guo; Shaoli Chu; Wenquan Niu
Journal:  Mol Biol Rep       Date:  2012-07-07       Impact factor: 2.316

4.  The angiotensin converting enzyme gene in cardiovascular disease.

Authors:  M Caulfield; J Newell-Price
Journal:  Br Heart J       Date:  1995-09

5.  Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass.

Authors:  H Schunkert; H W Hense; M Muscholl; A Luchner; S Kürzinger; A H Danser; G A Riegger
Journal:  Heart       Date:  1997-01       Impact factor: 5.994

6.  Should the contribution of ACE gene polymorphism to left ventricular hypertrophy be reconsidered?

Authors:  H Montgomery
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

Review 7.  The genomic architecture of sporadic heart failure.

Authors:  Gerald W Dorn
Journal:  Circ Res       Date:  2011-05-13       Impact factor: 17.367

8.  Renin-angiotensin gene polymorphism in children with uremia and essential hypertension.

Authors:  Ferenc Papp; Aaron L Friedman; Csaba Bereczki; Ibolya Haszon; Eva Kiss; Emöke Endreffy; Sándor Túri
Journal:  Pediatr Nephrol       Date:  2002-12-18       Impact factor: 3.714

9.  Early sign of atherosclerosis in slow coronary flow and relationship with angiotensin-converting enzyme I/D polymorphism.

Authors:  Halil Tanriverdi; Harun Evrengul; Hatice Mergen; Ceren Acar; Deniz Seleci; Omur Kuru; Seyhan Tanriverdi; Asuman Kaftan
Journal:  Heart Vessels       Date:  2007-01-26       Impact factor: 2.037

Review 10.  Cardiovascular disease in patients with chronic kidney disease.

Authors:  Julian Wright; Alastair Hutchison
Journal:  Vasc Health Risk Manag       Date:  2009-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.